Inflammation and Cardiovascular Cross Talk in Ischemic Vascular Diseases

Ischemic vascular diseases include different pathological events characterized by distinctive features but share the common hallmark of inflammation. In this light, myocardial infarction can be a good paradigm to summarize the different connections linking inflammation and the cardiovascular system during an ischemic event. The immune system and inflammation, through several cellular and soluble inflammatory mediators, play a crucial role in the local tissue structural changes of ischemic heart disease, with a different impact and outcome during acute myocardial infarction compared to the more chronic long-term inflammation. In response to acute damage and hemodynamic stress, there is expansion of resident immune cells and recruitment of extra cells involved in a critical cross talk with parenchymal cells. In other words, postischemic tissue repair is crucial to survival. Recruited inflammatory cells can remove debris and facilitate the repair process; conversely, unrestrained inflammation inhibits optimal healing leading to adverse events. Moreover, other mediators such as some key coagulation factors might influence innate immunity as well as cell-mediated reactions like healing, response to tissue injury, or inflammatory processes. Overall, as recently suggested, the different immune/inflammatory cell subsets act as messengers implicated in novel inflammatory networks that link different organ systems enlarging the continuum beyond the myocardium and blood vessels in a more integrative pathophysiology standpoint. This special issue aims to collect insights about this cross talk with a dual purpose: on the one hand to expand the comprehension on the mechanisms of action and impact of “old” inflammatory mediators and on the other to bring out “new” potential pathways and intermediates. The overall aim is to increase knowledge on the pathophysiological processes of ischemic vascular disease to improve diagnosis and treatment